The GLG Healthcare Practice provides access to a global network of more than 55,000 experts from across the entire healthcare industry including physicians, researchers, scientists, and healthcare industry executives.
The Healthcare Practice provides insight into issues affecting the pharmaceutical, biotechnology, medical device, and healthcare services sectors.
Leading Experts include Council Members from GLG Member Programs. The Gerson Lehrman Group® (GLG) LeaderSM Program is our premium Member ProgramSM. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.
Raw Materials Group
Joe Potter was a Business Development Manager at Potter Global Incorporated, a consulting firm that deals with the healthcare industry. Mr. Potter is knowledgeable in the field of gene splicing. He has experience in solving complex biological problems...
Johns Hopkins University - CC
William Matsui, MD, is an Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center and the Johns Hopkins School of Medicine in Maryland, since July 2008. Dr. Matsui specializes in clinical and laboratory examination of hematological...
Hospital of the University of Pennsylvania - CC
Samir Mehta, MD, is Orthopaedic Surgeon at the Hospital of the University of Pennsylvania. Previously, Dr. Mehta was Orthopaedic Surgeon and Assistant Professor of Orthopaedic Surgery in the Division of Orthopaedic Trauma at the University of Pennsylvania....
Partner, Hematologist and Medical Oncologist
Cancer Specialists of North Florida
Jeffrey A. Bubis, DO, FACOI, FACP, is a Managing Partner, Hematologist and Medical Oncologist at Cancer Specialists of North Florida, the largest private oncology practice in northeast Florida. The group provides comprehensive care to hematology and oncology...
Pathology Lab of Georgia
John Cochran, MD, is the Founder and Chief Executive Officer of Chestatee Pathology Associates in Atlanta, GA, since 2000. Dr. Cochran is Medical Director of two Atlanta-area hospital laboratories and founded the first independent podiatric pathology...
|Study Group Name||No. Members|
There are no upcoming GLG Live Meetings
245 U.S.-based neurologists share their opinion of Tysabri for the treatment of multiple sclerosis.
How will Revlimid's use change with this new data? How will Carfilzomib fit into a crowded market?
Reactions from ten top medical oncologists, powered by the GLG Healthcare CouncilsSM, regarding data presented by Amgen and Bayer at the 34th European Society of Medical Oncology (ESMO) Congress in Berlin the week of September 21, 2009.